THE TEST THAT DETECTS CONDITIONS BEFORE THE CHILD SHOWS SYMPTOMS

Babynext® helps you prevent damage caused by a diagnosis made too late.

THE TEST THAT DETECTS CONDITIONS BEFORE THE CHILD SHOWS SYMPTOMS

Babynext® helps you prevent damage caused by a diagnosis made too late.

It can happen that a child is affected by a certain pathology without showing symptoms.

Discovering genetic anomalies in advance represents an important prevention opportunity because it allows timely application of the most appropriate therapeutic paths, such as the use of drugs, changes in lifestyle or diet.

In addition, genetic analysis is valuable in determining the presence of alterations that cannot be identified with other types of exams, allowing for better healthcare planning.

From Eurofins Genoma’s experience comes Babynext®, which identifies genetic pathologies early on and facilitates the timely application of therapies.

Babynext Eurofins Genoma

Babynext® does its best for the serenity of your family.

What is Babynext®?

Babynext® is a non-invasive postnatal screening test that is performed on the baby with a simple oral swab. The extracted DNA is then analyzed to detect any anomalies related to over 200 genetic conditions.

It’s an early analysis that helps parents and pediatricians to identify these conditions in the early stages of the baby’s life, in order to prevent the onset of symptoms and/or cure them. For all conditions identified by Babynext®, a treatment is possible. The earlier these conditions are identified, the more prompt and timely the treatment will be.

Babynext Eurofins Genoma

Exome preservation

In addition to reporting on the genes investigated, Babynext® provides exome sequencing, the set of DNA regions that encode the DNA that contain the “instructions” necessary for protein production, whose data will be stored for 18 years.

More and more often, some clinical symptoms cannot be found in routine diagnosis. Genetic testing can solve this problem.

Exome preservation makes genetic data immediately available for a specific exam reducing waiting times for answers and the need for further testing.

Eurofins Genoma: by your children’s side, from birth to adulthood.

  • The exome will be stored according to the rules for storing digital data and these data will be accessible until the child reaches adulthood and then transferred to the adult.
  • If the child needs to undergo further exams in the future, he or she can always do so at our laboratories: having already stored his or her exome, we will start the analysis without long waits.
  • The results of these further exams will then be discussed in a new genetic consultation for the result.

Who is Babynext® recommended for?

It is advisable to carry out as soon as possible for a timely diagnosis and possible taking charge of the child. All children, from birth to 3 years even without apparent symptoms.

Exome preservation can also be extended to older brothers and sisters.

How is it performed?

The Babynext® test is performed with a simple mouth swab. You can request it from your trusted doctor or book it at one of our centers.

Genetic counseling pre- and post-test is included with Babynext®.

Conditions detected by Babynext®

Babynext® performs early screening for numerous genetic conditions and identifies them in the early stages of life, allowing parents and pediatricians to take prompt action in terms of clinical checks, treatment, and lifestyle modifications.

Clinical area/th>Some of the conditions/pathologies detected by the test
Hematology
  • Favism
  • Beta thalassemia
  • Sickle cell anemia
Endocrinology
  • Family thyroid disording
  • Congenital type 1 hypothyroidism
  • Congenital adrenal hyperplasia by deficit of 3-bet-hydroxistery dehydrogenase
Gastroenterology
  • Congenital defect of the synthesis of type 1, 2 and 3 bile acids
Immunology
  • Grave combined immunodeficiency by Ada deficit
  • Reticular dyscenesia
  • Agammaglobulinemia linked to the former
Metabolism
  • Galactosemia
  • Phenylchetonia
  • Tyrosinemia
Nefrology
  • Alport syndrome
  • Cistinuria A
  • Distal renal tubular acidosis
Oncology
  • Retinoblastoma
  • Predisposition to type 1 and 2 rabdoid tumor
  • Nefroblastoma or Wilms cancer
Otolaryngology
  • Pendred syndrome
  • Deafness with vestibular aqueduct enlargement
  • Cystic fibrosis
Syndromic
  • Type 1 neurofibromatosis

Clinical area

Hematology

Some of the conditions/pathologies detected by the test:

  • Favism
  • Beta thalassemia
  • Sickle cell anemia

Endocrinology

Some of the conditions/pathologies detected by the test:

  • Family thyroid disording
  • Congenital type 1 hypothyroidism
  • Congenital adrenal hyperplasia by deficit of 3-bet-hydroxistery dehydrogenase

Gastroenterology

Some of the conditions/pathologies detected by the test:

  • Congenital defect of the synthesis of type 1, 2 and 3 bile acids

Immunology

Some of the conditions/pathologies detected by the test:

  • Grave combined immunodeficiency by Ada deficit
  • Reticular dyscenesia
  • Agammaglobulinemia linked to the former

Metabolism

Some of the conditions/pathologies detected by the test:

  • Galactosemia
  • Phenylchetonia
  • Tyrosinemia

Nefrology

Some of the conditions/pathologies detected by the test:

  • Alport syndrome
  • Cistinuria A
  • Distal renal tubular acidosis

Oncology

Some of the conditions/pathologies detected by the test:

  • Retinoblastoma
  • Predisposition to type 1 and 2 rabdoid tumor
  • Nefroblastoma or Wilms cancer

Otolaryngology

Some of the conditions/pathologies detected by the test:

  • Pendred syndrome
  • Deafness with vestibular aqueduct enlargement
  • Cystic fibrosis

Syndromic

Some of the conditions/pathologies detected by the test:

  • Type 1 neurofibromatosis

Why choose Babynext®?

Early Diagnosis

Babynext® allows for the early identification of diseases, even before symptoms manifest.

Targeted Therapy

Babynext® allows the doctor to identify and develop a personalized therapeutic plan.

Cutting-Edge Technology

Babynext® combines screening over 200 genes, connected to 280 conditions, with whole exome sequencing.

Results Preserved Over Time

The exome data is stored and can be consulted until the child reaches adulthood.

Your essential resource for better prevention.

Functional

For all conditions identified by Babynext® there is a treatment, which may involve the use of drugs, supplements, or lifestyle changes based on the doctor’s recommendation.

Advanced

Uses innovative and sophisticated techniques.

Useful

The preservation of the exome allows for the data to be already available for future exams, greatly reducing wait times for answers.

Fast

Results are ready in 45 working days.

Quality. Excellence. Innovation.

Considered one of the most advanced European molecular diagnostic laboratories, it is an internationally recognized center for the great wealth of technologies and human resources that characterize it.

Since 1997 it has primarily operated as a diagnostic partner for genetic, cytogenetic and molecular analysis: it is a company active in research and boasts unrivaled knowledge and experience in the sector. It offers a combination of advanced technologies and patient care that ensure increasingly accurate diagnoses.

Babynext Eurofins Genoma

The laboratories, located within modern and high-tech facilities, are characterized by advanced instrumental and technological equipment, as well as high quality standards.

Eurofins Genoma provides a wide range of services among the most complete in the national and international territory, offering patients and their doctors innovative diagnostic solutions for any clinical need.

Contact us by sending an email to info@babynext.it or fill out this form

A specialist will contact you, free of charge and without obligation,to provide you with all the information you need.

EXPERIENCE.
COMPETENCE.
QUALITY.

For over 20 years, Eurofins Genoma has been an excellence center in the field of genetics and molecular biology, recognized internationally for its large technological and human resources.

Our laboratories, housed in modern and high-tech facilities, are characterized by advanced instrumental and technological equipment, as well as high-quality standards.

Since 1997 we have mainly operated as a diagnostic partner for genetic, cytogenetic and molecular analysis: we are a research-active company and boast significant knowledge and experience in the field.

We provide a wide range of services among the most complete in the national and international territory, offering patients and their doctors innovative diagnostic solutions for a wide range of genetic and molecular analysis.

Tests performed in Italy

3 laboratories equipped with the most innovative technologies

Quick
reporting

Tests distributed
globally

Over 20 years of experience
in genetics and molecular biology

Over 200,000 genetic tests per year

Personalized genetic counseling

Research department with numerous publications in prestigious international journals

customer service: +39 06.164161500

Rome

Laboratories and Medical Studies

Legal Headquarters and Research and Development Laboratory for Molecular Genetics
Via Castel Giubileo, 11 / 00138

Medical Genetics Laboratory and Molecular Diagnostics

Sampling and Consultations
Via Castel Giubileo, 62 / 00138

Milan

Molecular Genetics Laboratory and Medical Studies

Via Enrico Cialdini, 16 (Affori Centre) 20161

Florence

Laboratory and Medical Studies

Via Cavour, 168r 50121